Youngy Health Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Tour, Travel Related Services
  • ISIN: CNE1000015V4
CNY
5.03
-0.06 (-1.18%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

With a growth in Net Profit of 110.68%, the company declared Very Positive results in Mar 25

  • The company has declared positive results for the last 6 consecutive quarters
  • DEBTORS TURNOVER RATIO(HY) Highest at 14.51%
  • RAW MATERIAL COST(Y) Fallen by -15.74% (YoY)
  • CASH AND EQV(HY) Highest at CNY 1,312.1 MM
2

With ROE of 7.74%, it has a attractive valuation with a 2.30 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Tour, Travel Related Services

stock-summary
Market cap

CNY 3,255 Million (Small Cap)

stock-summary
P/E

30.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.45

stock-summary
Return on Equity

9.42%

stock-summary
Price to Book

2.88

Revenue and Profits:
Net Sales:
179 Million
(Quarterly Results - Jun 2025)
Net Profit:
21 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
13.54%
0%
13.54%
6 Months
12.78%
0%
12.78%
1 Year
36.68%
0%
36.68%
2 Years
103.64%
0%
103.64%
3 Years
28.32%
0%
28.32%
4 Years
30.99%
0%
30.99%
5 Years
81.59%
0%
81.59%

Youngy Health Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
5.14%
EBIT Growth (5y)
17.50%
EBIT to Interest (avg)
33.28
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.57
Sales to Capital Employed (avg)
0.60
Tax Ratio
25.24%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.86%
ROE (avg)
5.32%

Valuation key factors

Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
2.30
EV to EBIT
19.43
EV to EBITDA
15.10
EV to Capital Employed
4.76
EV to Sales
2.35
PEG Ratio
0.28
Dividend Yield
NA
ROCE (Latest)
24.49%
ROE (Latest)
7.74%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 15.19% vs 39.00% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 75.83% vs -12.41% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "179.00",
          "val2": "155.40",
          "chgp": "15.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "25.50",
          "val2": "17.00",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.60",
          "val2": "2.10",
          "chgp": "71.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "21.10",
          "val2": "12.00",
          "chgp": "75.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "108.40%",
          "val2": "64.30%",
          "chgp": "4.41%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 30.39% vs 14.37% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 57.76% vs -68.57% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "684.00",
          "val2": "524.60",
          "chgp": "30.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "91.70",
          "val2": "61.80",
          "chgp": "48.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.00",
          "val2": "2.40",
          "chgp": "-58.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "5.70",
          "val2": "14.00",
          "chgp": "-59.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "66.10",
          "val2": "41.90",
          "chgp": "57.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "91.80%",
          "val2": "63.90%",
          "chgp": "2.79%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary

Jun'25
Jun'24
Change(%)
Net Sales
179.00
155.40
15.19%
Operating Profit (PBDIT) excl Other Income
25.50
17.00
50.00%
Interest
0.00
0.00
Exceptional Items
3.60
2.10
71.43%
Consolidate Net Profit
21.10
12.00
75.83%
Operating Profit Margin (Excl OI)
108.40%
64.30%
4.41%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 15.19% vs 39.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 75.83% vs -12.41% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
684.00
524.60
30.39%
Operating Profit (PBDIT) excl Other Income
91.70
61.80
48.38%
Interest
1.00
2.40
-58.33%
Exceptional Items
5.70
14.00
-59.29%
Consolidate Net Profit
66.10
41.90
57.76%
Operating Profit Margin (Excl OI)
91.80%
63.90%
2.79%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 30.39% vs 14.37% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 57.76% vs -68.57% in Dec 2023

stock-summaryCompany CV
About Youngy Health Co., Ltd. stock-summary
stock-summary
Youngy Health Co., Ltd.
Tour, Travel Related Services
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available